Transparency Reporting Solution

• Healthcare providers (HCPs) licensed, certified or registered in Nevada
• Pharmacies and employees thereof
• Operators and employees of medical facilities
• Persons licensed or certified under provisions of title 57 of NRS

A list of HCPs who have been provided by a pharmaceutical sales representative:

• Any compensation exceeding $10, or total compensation exceeding $100 in aggregate
• Name and manufacturer of each prescription drug for which a free sample was provided
• Name of each person who was given a free sample

Data points to be disclosed: Manufacturer name, Representative State ID, Transaction Date, Recipient Name, Professional Designation, NPI, Zip Code, Compensation Amount & Type; and if a sample drug was provided: Drug Name, NDC.

• Advanced practice registered nurses (APRNs)
• Physician assistants (PAs)
• Veterinarians
• Dental therapists

Payments, reimbursement or other compensation paid to HCPs registered and practicing in Minnesota during the calendar year in which the transfer of value is $100 or more to a particular covered recipient.

Data points: Name of practitioner, Professional designation, Address, Value of payment, Specific reason for payment.

• Professional samples provided to prescribers for free distribution to patients
• Transfers of value with combined retail value of $50 or less in a calendar year
• Payment to sponsor of a medical conference used solely for bona fide educational purposes
• Honoraria or payments less than $100 annually for faculty at professional conferences
• Compensation for consulting services less than $100 annually

• All licensed HCPs including nurses, CDEs, registered dieticians, radiology technicians
• Non-teaching hospitals/clinics, Universities, Patient advocacy associations
• All licensed healthcare facilities (hospice, long-term care, dialysis, etc.)

• All expenses associated with advertising, marketing and direct promotion of prescription drugs through radio, television, magazines, newspapers, direct mail and telephone communications to D.C. residents
• Any expenditure for consulting and honoraria fees, charitable grants, educational programs, gifts, meals or entertainment over $25 in value, and travel reimbursement for District healthcare professionals
• Aggregate cost of employees or contractors who directly or indirectly engage in reportable activity

• Expenses of $25 or less
• Compensation and reimbursement for expenses in connection with a bona fide clinical trial of a new vaccine, therapy, or treatment that is of modest value
• Scholarships for recipients attending significant educational, scientific, or policy-making conferences

An individual authorized, certified, and licensed under the laws of Oregon to prescribe, dispense or provide pharmaceutical products to patients for treatment, diagnosis, injury, congenital or disease prevention.

Interactions healthcare professionals have with pharmaceutical representatives including video conference, email, telephonic conversation, in-person meetings, or leaving material/drug samples.

• HCP's License Type, Name, Address, NPI or Oregon State License Number
• Representative's License Number and Name
• Date, location, and duration of interaction
• Drug names promoted, monetary value of samples
• Gifts given and description of compensation

No exemptions.

• Doctor, Dentist, Pharmacist
• Nurse practitioner
• Audiologist, Podiatrist
• Physical therapist

• Product education and training
• Modest meals in conjunction with product education and training
• Honoraria, consultant, speaker fees and related out-of-pocket expenses
• Reasonable travel and lodging necessary for training
• Demonstration or evaluation units
• Educational gifts (journal articles, anatomical models, textbooks)
• Charitable donations

Any pharmaceutical manufacturer that employs individuals to perform the duties of pharmaceutical sales representatives in the U.S.

• Independently practicing advanced practice registered nurses (APRNs) — Connecticut provides a list of applicable APRNs

Payment or other transfer of value, except when the transfer is made indirectly to an APRN via a third party and the applicable manufacturer is unaware of the APRN's identity or meets the exclusion criteria set by CMS Open Payments.

Data points to be disclosed:

• Manufacturer name
• Contact person name
• Contact person email
• Contact person's phone number
• Total value of payment to APRN

Any pharmaceutical manufacturer that employs individuals to perform the duties of pharmaceutical sales representatives in the U.S.

• All prescribing practitioners and pharmacists with whom Connecticut sales representatives interact
• Contact made with or a sample provided to a prescribing practitioner, a pharmacist, or an office staff member by a CT sales representative shall be reported

Data points to be disclosed:

• Name of Firm
• Name of Individual Sales Representative
• No. of Contacts
• CMS Classification / Specialty
• Gift value ($)
• 11 Digit NDC Code
• Drug Name
• Drug Strength
• WAC Price / List Price ($)
• Total Number of Samples in the Package
• Number of Samples Gifted
• Gifted Value ($)

• Only report those interactions that were done in the previous reporting year
• Manufacturers do not have to report indirect spend to a third party where the manufacturer is unaware of the recipient's identity

• Healthcare professionals
• Academic institutions
• Non-profit hospital foundations
• Educational and patient organizations located in or providing services in Vermont
• Members of the Green Mountain Care Board

• Samples (separate disclosure template)
• Device loaners (allowed for up to 120 days)
• Clinical and research payments
• Compensation for bona fide services
• Sponsorship and fellowship payments
• Educational materials & Demo/evaluation units
• Coupons, vouchers and discount cards
• Charitable contributions

Manufacturers and authorized distributors of applicable drugs must submit the identity and quantity of drug samples requested and distributed, aggregated by:

• Name, address, professional designation of the practitioner who made the request
• Signature of the practitioner or their designee for receiving samples

Data points to be disclosed: Submission year, Business name, Practitioner professional designation, First/middle/last name, Address, Drug trade name and dosage, Package size, Package/quantity requested, Package/quantity received, Signature received.

When a manufacturer and authorized distributor of record (ADR) both have records regarding the same drug sample request or distribution, only one of the two entities should submit the required information to FDA.